Current Chemical Genomics and Translational Medicine · 2014 · 43 citations · 27 references
MedicineCancer BiologyOncologyBiomedical ImagingMolecular ImagingMolecular OncologyCancer Stem Cell BiologyCancer Stem CellsMolecular Imaging In OncologyPreclinical Cancer ModelsQuantitative Molecular ImagingTumor ImagingCancer Cell Culture ModelsCancer Stem-like CellsFluorescence QuantificationHigh-content ScreeningImage-based ScreeningQuantitative Cell ImagingSpheroid Culture ModelsSpheroid Models
The multi cellular tumor spheroid (MCTS) model has been used for decades with proven superiority over monolayer cell culture models at recapitulating in vivo tumor growth. Yet its use in high-throughput drug discovery has been limited, particularly with image based screening, due to practical and technical hurdles. Here we report a significant advance in utilizing live MCTS models for high-content image based drug discovery. Using a validated GFP reporter (CK5Pro-GFP) of luminal breast cancer stem cells (CSC), we developed an algorithm to quantify changes in CK5Pro-GFP expression levels for individual Z-stack planes (local) or as maximal projections of the summed Z-stacks (global) of MCTS. From these image sets, we can quantify the cross-sectional area of GFP positive cells, the fluorescence intensity of the GFP positive cells, and the percent of spheroid cross-sectional area that expresses CK5Pro-GFP.We demonstrate that acquiring data in this manner can be done in real time and is statistically robust (Z'=0.85) for use in primary high-content screening cancer drug discovery.
27
Spheroid-based drug screen: considerations and practical approach
Juergen Friedrich, Claudia Seidel, Reinhard Ebner et al. · Nature Protocols · 2009 · 1.7K citations